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Drugs of abuse result in complex changes 
in neurocircuit of reward and stress. 
Whilst most of these changes affect neu-
rons, the role of additional cell types, such 
as glia, in the development of tolerance 
and related neuroplastic changes during 
drug taking, addiction, and withdrawal 
is also emerging. For instance, astrocytes, 
which play an essential role in gluta-
matergic neurotransmission, as well as 
in energetic and growth factor support 
of neurons, are significantly affected by 
drugs of abuse (Miguel-Hidalgo, 2009). 
Furthermore, the role of microglia in tai-
loring neuronal connectivity, transmitter 
metabolism, and drug-induced neuroin-
flammation might also be important in 
physiology of neurons at the addiction-
related brain circuitries.
Microglia belong to monocyte/mac-
rophage linage and are resident cells of 
the innate immune system in the brain. 
Microglia have at least three, function-
ally and morphologically distinct forms 
(Papaleo et al., 2008; Olah et al., 2011). 
Under normal conditions (1) resting 
microglia, through their highly mobile 
filopodia continuously survey the brain 
parenchyma (Nimmerjahn et al., 2005). 
Microglia became activated (2) in response 
to various danger signals posed by neurons 
and/or astrocytes (Davalos et al., 2005). At 
this stage, microglia are recruited and have 
local protective effects via regulated release 
of cytokines and phagocytosis of cellular 
debris. At certain point however, microglia 
gain reactive phenotype (3) characterized 
by uncontrolled release of inflammatory 
mediators. These cells furiously attack 
neurons, became neurotoxic and extend 
the damage (Banati and Graeber, 1994). 
It is noteworthy that different insults may 
converge upon microglial cell population 
and potentiate each other to worsen the 
outcome of the response (Zou et al., 2011). 
However, like macrophages, microglial cells 
are functionally polarized into  different 
phenotypic activation states, referred 
as classical (M1) and alternative (M2). 
Alternatively activated microglia express 
anti-inflammatory cytokines and involved 
in tissue protection and repair.
Activated microglia may contribute to 
addiction-related neuroplastic changes by 
several ways, such as release of proinflam-
matory cytokines, synaptic remodeling, 
neurochemical interaction with excitatory 
transmission and phagocytosis of newborn 
neurons and cellular debris.
Drug-relateD receptors on 
microglia
Microglia posses several neurotransmitter 
and gliotransmitter receptors that might 
be involved in their activation during 
drug addiction. Activation of microglia 
by addictive drugs results in a proinflam-
matory dominance of the innate immune 
system, which is then critically synergize on 
the neurocircuit of reward and dependence 
(Coller and Hutchinson, 2012). For instance, 
microglia, similar to other cell of this lin-
age (i.e., macrophages/monocytes), express 
opioid receptors (Bidlack, 2000; Zou et al., 
2011) although their direct role in release 
of IL-1α and β, TNFα remains to be estab-
lished. Furthermore, it has recently been 
demonstrated that morphine binds to an 
accessory protein (MD-2) of Toll-like recep-
tor 4 (TLR-4) and initiate release of proin-
flammatory cytokines from microglia and 
CNS endothelial cells (Wang et al., 2012). 
By contrast, select phytocannabinoids 
have anti-inflammatory (Puffenbarger 
et al., 2000) and neuroprotective (Martin-
Moreno et al., 2011) effects that are medi-
ated by cannabinoid receptors (CB1R and/
or CB2R) which have been identified on 
microglia (Cabral and Marciano-Cabral, 
2005; Racz et al., 2008).
Acute and chronic exposure to alcohol 
also results in region specific activation of 
glial cells (astrocytes and microglia) in dose- 
and time-dependent manner (Crews et al., 
2011). Recent work in TLR-4 deficient mice 
highlighted the critical role of lipid rafts, 
TLR-4 and its interaction with MD-2 and 
CD14 accessory proteins in alcohol-induced 
neuroinflammation (Alfonso-Loeches 
et al., 2011; Coller and Hutchinson, 2012).
It is noteworthy that other abused drugs 
such as cocaine and methamphetamine also 
provoke proinflammatory immune signal-
ing in the CNS (Lee et al., 2009), suggesting 
that neuroinflammation is indeed a general 
and critical component in the development 
and maintenance of drug abuse. To support 
this hypothesis it has been demonstrated 
that agents blocking microglia activation 
(minocycline, ibudilast) could inhibit drug-
induced cytokine, chemokine, and behavio-
ral responses (Hutchinson et al., 2008, 2009; 
Agrawal et al., 2011; Schwarz et al., 2011). 
For instance, it has recently been shown that 
p38 signaling in the microglia in the nucleus 
accumbens is involved in acquisition and 
maintenance of morphine-induced condi-
tioned place preference (CPP) that can be 
suppressed by microglia inhibitors (Zhang 
et al., 2012).
On the other hand, opiate antagonist-
based addiction therapy inhibits innate 
immune gene expression (Liu et al., 2000). 
It should be noted, however, that neuroin-
flammation per se does not result in addic-
tion, however may worsen drug effects in 
addicted individuals (Bruce-Keller et al., 
2008).
microglia anD Drug-inDuceD 
morphological plasticity
It is well documented that exposure to vari-
ous addictive drugs produces permanent 
morphological and physiological changes in 
dendrites, dendritic arborization, dendritic 
spines, and synaptic density in brain regions 
that are implicated in reward, decision mak-
ing, and inhibitory control of behavior. For 
instance, stimulants such as cocaine, amphet-
amine, and nicotine (self-administration or 
repeated dosing) result in an increase of 
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spine density on medium spiny neurons of 
the nucleus accumbens and on the apical den-
drites of pyramidal neurons of the prefrontal 
cortex (Robinson and Kolb, 1999, 2004). On 
the other hand, depressants, such morphine, 
significantly reduce spine densities and den-
dritic branching in these areas (Robinson and 
Kolb, 1999). Considerable amount of infor-
mation has been accumulated over the years 
on the cellular and molecular mechanisms 
that govern drug experience-induced func-
tional and morphological plasticity (Nestler, 
2004; Hyman et al., 2006). With recent emer-
gence of microglia as effectors in neural circuit 
reorganization, “a new player” should be con-
sidered in drug-induced neuronal plasticity 
(Graeber, 2010). During development, micro-
glia engulf, and phagocytose synapses via 
fractalkine–fractalkine receptor (CX3CR1) 
dependent manner, and play an important 
role in synaptic “pruning” in postnatal brain 
development (Paolicelli et al., 2011). It has 
recently been suggested that microglia may 
actively contribute to the experience-depend-
ent modification or elimination of a specific 
subset of synapses in the adult healthy brain as 
well (Graeber, 2010). Indeed, microglial pro-
cesses make specific contacts with synapses 
especially with  presynaptic elements and the 
timing of these contacts is activity-dependent 
(Wake et al., 2009). Recent in vivo, two pho-
ton imaging and electron microscopy studies 
have revealed that microglia processes were 
associated with dendritic spines in experience-
dependent manner, supporting the role of 
microglia in synaptic remodeling (Wake et al., 
2009; Tremblay, 2012; Tremblay et al., 2012). 
Based on the significant remodeling of drug-
related brain areas and the role that micro-
glia plays in morphological plasticity during 
development and in the healthy adult brain, 
one can hypothesize microglia significantly 
contribute to morphological and physiologi-
cal synaptic plasticity in the addicted brain 
as well.
microglia anD Drug-inDuceD 
neurochemical changes
Evidences have been accumulated over the 
years to support the involvement of gluta-
matergic neurotransmission in the mecha-
nisms of drug dependence involving the 
dopaminergic reward circuit. Microglia 
contain enzyme machinery [indoleam-
ine 2,3 dioxygenase (IDO)] to produce 
quinolinic acid (QUIN). QUIN promotes 
glutamate release through activation of 
N-methyl-d-aspartate (NMDA) receptors. 
Quinolinic acid also induces oxidative 
stress, which in combination with gluta-
mate release may contribute to CNS exci-
totoxicity. For instance in alcoholic patients 
ethanol may generate significant levels of, 
quinolinic acid, possibly even toxic levels in 
localized brain areas (Morgan, 1991).
microglia anD Drug-inDuceD 
neuroDegeneration
Microglia play a pivotal role in maintain-
ing the balance between neurogenesis and 
neuronal cell death in the brain via phago-
cytosis of apoptotic cells and necrotic debris. 
Neuronal stem cells and progenitors in the 
subgranular zone of the hippocampus give 
rise to newborn granular cells into the hip-
pocampal circuit to participate learning, 
memory, fear, and mood regulation that are 
also important aspects of the addictive behav-
ior. Under quiescent conditions microglia is 
ramified and seems to be neuroprotective, 
supporting neurogenesis through their inter-
action with T cells and by expressing MHCII 
and the neurotrophic factor insulin growth 
factor (IGF)-1. At this stage, microglia is very 
efficiently engulf apoptotic cells. However, 
addictive drugs decrease neurogenesis in 
the dentate gyrus of the hippocampus and 
Figure 1 | Schematic summary of microglia (shown in green) – neuron (shown in blue) interaction relevant to neuroplasticity in addiction.
Kovács Microglia and addiction
Frontiers in Molecular Neuroscience www.frontiersin.org June 2012 | Volume 5 | Article 74 | 2
Gross, C. T. (2011). Synaptic pruning by microglia 
is necessary for normal brain development. Science 
333, 1456–1458.
Papaleo, F., Ghozland, S., Ingallinesi, M., Roberts, A. J., 
Koob, G. F., and Contarino, A. (2008). Disruption 
of the CRF(2) receptor pathway decreases 
the somatic expression of opiate withdrawal. 
Neuropsychopharmacology 33, 2878–2887.
Puffenbarger, R. A., Boothe, A. C., and Cabral, G. A. (2000). 
Cannabinoids inhibit LPS-inducible cytokine mRNA 
expression in rat microglial cells. Glia 29, 58–69.
Racz, I., Nadal, X., Alferink, J., Banos, J. E., Rehnelt, 
J., Martin, M., Pintado, B., Gutierrez-Adan, A., 
Sanguino, E., Manzanares, J., Zimmer, A., and 
Maldonado, R. (2008). Crucial role of CB(2) cannab-
inoid receptor in the regulation of central immune 
responses during neuropathic pain. J. Neurosci. 28, 
12125–12135.
Robinson, T. E., and Kolb, B. (1999). Morphine alters the 
structure of neurons in the nucleus accumbens and 
neocortex of rats. Synapse 33, 160–162.
Robinson, T. E., and Kolb, B. (2004). Structural plas-
ticity associated with exposure to drugs of abuse. 
Neuropharmacology 47(Suppl. 1), 33–46.
Schwarz, J. M., Hutchinson, M. R., and Bilbo, S. D. (2011). 
Early-life experience decreases drug-induced reinstate-
ment of morphine CPP in adulthood via microglial-
specific epigenetic programming of anti-inflammatory 
IL-10 expression. J. Neurosci. 31, 17835–17847.
Tremblay, M. E. (2012). The role of microglia at synapses 
in the healthy CNS: novel insights from recent imag-
ing studies. Neuron Glia Biol. 1–10.
Tremblay, M. E., Lowery, R. L., and Majewska, A. K. (2012). 
Microglial interactions with synapses are modulated 
by visual experience. PLoS Biol. 8, e1000527. doi: 
10.1371/journal.pbio.1000527
Wake, H., Moorhouse, A. J., Jinno, S., Kohsaka, S., and 
Nabekura, J. (2009). Resting microglia directly moni-
tor the functional state of synapses in vivo and deter-
mine the fate of ischemic terminals. J. Neurosci. 29, 
3974–3980.
Wang, X., Loram, L. C., Ramos, K., De Jesus, A. J., Thomas, 
J., Cheng, K., Reddy, A., Somogyi, A. A., Hutchinson, 
M. R., Watkins, L. R., and Yin, H. (2012). Morphine 
activates neuroinflammation in a manner paral-
lel to endotoxin. Proc. Natl. Acad. Sci. U.S.A. 109, 
6325–6330.
Zhang, X. Q., Cui, Y., Cui, Y., Chen, Y., Na, X. D., Chen, F. 
Y., Wei, X. H., Li, Y. Y., Liu, X. G., and Xin, W. J. (2012). 
Activation of p38 signaling in the microglia in the 
nucleus accumbens contributes to the acquisition 
and maintenance of morphine-induced conditioned 
place preference. Brain Behav. Immun. 26, 318–325.
Zou, S., Fitting, S., Hahn, Y. K., Welch, S. P., El-Hage, 
N., Hauser, K. F., and Knapp, P. E. (2011). Morphine 
potentiates neurodegenerative effects of HIV-1 Tat 
through actions at mu-opioid receptor-expressing 
glia. Brain 134, 3616–3631.
Received: 02 May 2012; accepted: 25 May 2012; published 
online: 13 June 2012.
Citation: Kovács KJ (2012) Microglia and drug-induced 
plasticity in reward-related neuronal circuits. Front. Mol. 
Neurosci. 5:74. doi: 10.3389/fnmol.2012.00074
Copyright © 2012 Kovács. This is an open-access arti-
cle distributed under the terms of the Creative Commons 
Attribution Non Commercial License, which permits non-
commercial use, distribution, and reproduction in other 
forums, provided the original authors and source are credited.
abuse: mechanisms, mediators and new therapeu-
tic approaches for prediction and treatment of drug 
dependence. Pharmacol. Ther. 134, 219–245.
Crews, F. T., Zou, J., and Qin, L. (2011). Induction of innate 
immune genes in brain create the neurobiology of 
addiction. Brain Behav. Immun. 25(Suppl. 1), S4–S12.
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., 
Jung, S., Littman, D. R., Dustin, M. L., and Gan, W. 
B. (2005). ATP mediates rapid microglial response to 
local brain injury in vivo. Nat. Neurosci. 8, 752–758.
Eisch, A. J., and Harburg, G. C. (2006). Opiates, psy-
chostimulants, and adult hippocampal neurogen-
esis: insights for addiction and stem cell biology. 
Hippocampus 16, 271–286.
Graeber, M. B. (2010). Changing face of microglia. Science 
330, 783–788.
Hutchinson, M. R., Lewis, S. S., Coats, B. D., Skyba, D. 
A., Crysdale, N. Y., Berkelhammer, D. L., Brzeski, A., 
Northcutt, A., Vietz, C. M., Judd, C. M., Maier, S. F., 
Watkins, L. R., and Johnson, K. W. (2009). Reduction 
of opioid withdrawal and potentiation of acute opioid 
analgesia by systemic AV411 (ibudilast). Brain Behav. 
Immun. 23, 240–250.
Hutchinson, M. R., Northcutt, A. L., Chao, L. W., Kearney, J. 
J., Zhang, Y., Berkelhammer, D. L., Loram, L. C., Rozeske, 
R. R., Bland, S. T., Maier, S. F., Gleeson, T. T., and Watkins, 
L. R. (2008). Minocycline suppresses morphine-induced 
respiratory depression, suppresses morphine-induced 
reward, and enhances systemic morphine-induced anal-
gesia. Brain Behav. Immun. 22, 1248–1256.
Hyman, S. E., Malenka, R. C., and Nestler, E. J. (2006). 
Neural mechanisms of addiction: the role of reward-
related learning and memory. Annu. Rev. Neurosci. 
29, 565–598.
Lee, C. T., Lehrmann, E., Hayashi, T., Amable, R., Tsai, S. 
Y., Chen, J., Sanchez, J. F., Shen, J., Becker, K. G., and 
Freed, W. J. (2009). Gene expression profiling reveals 
distinct cocaine-responsive genes in human fetal CNS 
cell types. J. Addict. Med. 3, 218–226.
Liu, B., Du, L., and Hong, J. S. (2000). Naloxone protects rat 
dopaminergic neurons against inflammatory damage 
through inhibition of microglia activation and super-
oxide generation. J. Pharmacol. Exp. Ther. 293, 607–617.
Mandyam, C. D., and Koob, G. F. (2012). The addicted 
brain craves new neurons: putative role for adult-born 
progenitors in promoting recovery. Trends Neurosci. 
35, 250–260.
Martin-Moreno, A. M., Reigada, D., Ramirez, B. G., 
Mechoulam, R., Innamorato, N., Cuadrado, A., and 
De Ceballos, M. L. (2011). Cannabidiol and other 
cannabinoids reduce microglial activation in vitro 
and in vivo: relevance to Alzheimer’s disease. Mol. 
Pharmacol. 79, 964–973.
Miguel-Hidalgo, J. J. (2009). The role of glial cells in drug 
abuse. Curr. Drug Abuse Rev. 2, 72–82.
Morgan, P. F. (1991). Is quinolinic acid an endogenous 
excitotoxin in alcohol withdrawal? Med. Hypotheses 
36, 118–121.
Nestler, E. J. (2004). Molecular mechanisms of drug 
addiction. Neuropharmacology 47(Suppl. 1), 24–32.
Nimmerjahn, A., Kirchhoff, F., and Helmchen, F. (2005). 
Resting microglial cells are highly dynamic surveillants 
of brain parenchyma in vivo. Science 308, 1314–1318.
Olah, M., Biber, K., Vinet, J., and Boddeke, H. W. (2011). 
Microglia phenotype diversity. CNS Neurol. Disord. 
Drug Targets 10, 108–118.
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., 
Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, 
T. A., Guiducci, E., Dumas, L., Ragozzino, D., and 
in the prefrontal cortex (Eisch and Harburg, 
2006) and activated microglia might be 
involved in this process as well. It has been 
hypothesized that new neurons may block 
memories associated with the contextual 
reinstatement of drug seeking or enhance 
extinction learning. Thus, the reduction in 
neurogenesis (i.e., a reduction in neuronal 
turnover) that is observed after self-admin-
istration of various drugs of abuse may result 
in a more robust and long-lasting memory of 
drug taking and seeking or decrease extinc-
tion learning (for review: Mandyam and 
Koob, 2012). In response to drug-induced 
microglia activation and proinflammatory 
environment the phagocytic potential of 
the microglia is further enhanced, leading 
to neurodegeneration.
In summary, microglia are emerging 
contributors of drug-induced morphologi-
cal and physiological plasticity by promot-
ing neuroinflammation through release of 
pro-inflammatory cytokines, by their active 
role in synaptic remodeling, involvement in 
excitotoxic neurochemical changes, and by 
phagocytic activity of newborn progenitors 
(Figure 1). Based on these facts microglia 
might be a potential target for the therapy 
of drug addiction.
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